Clinical outcomes using accelerated partial breast irradiation in patients with invasive lobular carcinoma

International Journal of Radiation Oncology Biology Physics

Volumn 81, Issue 4, 2011, Pages

  Shah, Chirag ^a   Wilkinson, J Ben ^a   Shaitelman, Simona ^a   Grills, Inga ^a   Wallace, Michelle ^a   Mitchell, Christina ^a   Vicini, Frank ^a  

^a OAKLAND UNIVERSITY WILLIAM BEAUMONT SCHOOL OF MEDICINE   (United States)

Author keywords

APBI; Breast cancer; Breast conservation therapy; Lobular carcinoma; Partial breast irradiation

Indexed keywords

APBI; BREAST CANCER; BREAST CONSERVATION THERAPY; LOBULAR CARCINOMA; PARTIAL BREAST IRRADIATION;

CHEMOTHERAPY; IRRADIATION; PATHOLOGY; PATIENT MONITORING; TUMORS; TWO TERM CONTROL SYSTEMS;

PATIENT TREATMENT;

ANTINEOPLASTIC AGENT;

ACCELERATED PARTIAL BREAST IRRADIATION; ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; FOLLOW UP; HUMAN; INVASIVE DUCTAL CARCINOMA; INVASIVE LOBULAR CARCINOMA; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 80255131344     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.04.050     Document Type: Article

References (20)

1. C.I. Li, B.O. Anderson, and P. Porter Changing incidence rate of invasive lobular breast carcinoma among older women Cancer 88 2000 2561 2569 (Pubitemid 30331964)
2. T.N. Vo, F. Meric-Bernstam, and M. Yi Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma Am J Surg 192 2006 552 555 (Pubitemid 44344191)
3. M. Cristofanilli, A. Gonzalez-Angulo, and N. Sneige Invasive lobular carcinoma classic type: Response to primary chemotherapy and survival outcomes J Clin Oncol 23 2005 41 48 (Pubitemid 41702621)
4. G. Arpino, V.J. Bardou, and G.M. Clark Infiltrating lobular carcinoma of the breast: Tumor characteristics and clinical outcome Breast Cancer Res 6 2004 149 156
5. M.S. Moran, Q. Yang, and B.G. Haffty Yale University experience of early-stage invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC) treated with breast conservation treatment (BCT): Analysis of clinical-pathologic features, long-term outcomes, and molecular expression of COX-2, Bcl-2, and p53 as a function of histology Breast J 15 2009 571 578
6. B.D. Smith, D.W. Arthur, and T.A. Buchholz Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO) Int J Radiat Oncol Biol Phys 74 2009 987 1001
7. G.G. Ribeiro, B. Magee, and R. Swindell The Christie Hospital breast conservation trial: An update at 8 years from inception Clin Oncol 5 1993 278 283 (Pubitemid 24009003)
8. V. Strnad, G. Hildebrandt, and R. Pötter Accelerated partial breast irradiation: 5-year results of the German-Austrian Multicenter Phase II Trial Using Interstitial Multicatheter Brachytherapy Alone After Breast-Conserving Surgery Int J Radiat Oncol Biol Phys 2010 Jun 2 (Epub)
9. G. Peiro, B.A. Bornstein, and J.L. Conolly The influence of infiltrating lobular carcinoma on the outcome of patients treated with breast-conserving surgery and radiation therapy Breast Cancer Res Treat 59 2000 49 54 (Pubitemid 30153897)
10. X. Sastre-Garau, M. Jouve, and B. Asselain Infiltrating lobular carcinoma of the breast: Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns Cancer 77 1996 113 120 (Pubitemid 26002745)
11. M.C. Weiss, B.L. Fowble, and L.J. Solin Outcome of conservative therapy for invasive breast cancer by histologic subtype Int J Radiat Oncol Biol Phys 23 1992 941 947
12. M.J. Silverstein, B.S. Lewinsky, and J.R. Waisman Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma? Cancer 73 1994 1673 1677 (Pubitemid 24085268)
13. J.R. White, G.S. Gustafson, and K. Wimbish Conservative surgery and radiation therapy for infiltrating lobular carcinoma of the breast. The role of preoperative mammograms in guiding treatment Cancer 74 1994 640 647 (Pubitemid 24217628)
14. L. Livi, F. Paiar, and F.B. Buonamici Accelerated intensity modulated external radiotherapy as a new technical approach to treat the index quadrant after conserving surgery in early breast cancer: A preliminary study Tumori 91 2005 227 232 (Pubitemid 41076127)
15. T. Nose, Y. Komoike, and K. Yoshida A pilot study of wider use of accelerated partial breast irradiation: Intraoperative margin directed re-excision combined with sole high-dose-rate interstitial brachytherapy Breast Cancer 13 2006 289 299
16. S. Mussari, W. Sabino Della Sala, and L. Busana Full-dose intraoperative radiotherapy with electrons in breast cancer. First report on late toxicity and cosmetic results from a single-institution experience Strahlenther Onkol 182 2006 589 595 (Pubitemid 44484271)
17. I.S. Fentiman, V. Deshmane, and D. Tong Caesium(137) implant as sole radiation therapy for operable breast cancer: A phase II trial Radiother Oncol 71 2004 281 285 (Pubitemid 38686665)
18. Z. Poti, C. Nemeskeri, and A. Fekeshazy Partial breast irradiation with interstitial 60CO brachytherapy results in frequent grade 3 or 4 toxicity. Evidence based on a 12-year follow-up of 70 patients Int J Radiat Oncol Biol Phys 58 2004 1022 1033 (Pubitemid 38314782)
19. A. Luini, R. Orecchia, and G. Gatti The pilot trial on intraoperative radiotherapy with electrons (ELIOT): Update on the results Breast Cancer Res Treat 93 2005 55 59 (Pubitemid 41355991)
20. B. Johansson, L. Karlsson, and G. Liljegren Pulsed dose rate brachytherapy as the sole adjuvant radiotherapy after breast-conserving surgery of T1-T2 breast cancer: First long time results from a clinical study Radiother Oncol 90 2009 30 35